SEC Form 4 · accession 0001578563-19-000002
Avalo Therapeutics, Inc. · AVTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Phil Gutry
Director
Period of report
Dec 31, 2018
Accepted (ET)
Jan 2, 2019 · 4:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001534120
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $3.23 | Dec 31, 2018 | A | 3,439 | A | Dec 31, 2018 | Dec 30, 2028 | Common Stock | 3,439 | 3,439 | D |